Citations (97)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Iulia Fratila & Liza Berdychevsky. (2024) Aiming “High” in College: Phenomenological Meanings of Drug Consumption in/as Leisure through the Lens of Existential Authenticity. Leisure Sciences 46:3, pages 296-314.
Read now
Read now
Nin Kirkham & Chris Letheby. (2024) Psychedelics and environmental virtues. Philosophical Psychology 37:2, pages 371-395.
Read now
Read now
Jason B. Luoma, Brian Pilecki, Alan K. Davis & Sarah M. Smith. (2023) Predictors of attitudes toward psychedelics among psychologists in the USA. Drugs: Education, Prevention and Policy 30:6, pages 543-549.
Read now
Read now
Petter Johnstad. (2023) Entheogenic Spirituality: Characteristics of Spiritually Motivated Psychedelics Use. The International Journal for the Psychology of Religion 33:4, pages 380-396.
Read now
Read now
F. LeRon Shults. (2023) Studying Close Entity Encounters of the Psychedelic Kind: Insights from the Cognitive Evolutionary Science of Religion. The International Journal for the Psychology of Religion 33:4, pages 294-308.
Read now
Read now
Marcio S. C. Longo, Bheatrix Bienemann, Marco Multedo, Marco Aurelio Negreiros, Eduardo Schenberg & Daniel C. Mograbi. (2023) The Association of Classic Serotonergic Psychedelic Use and Intention of Future Use with Nature Relatedness. Journal of Psychoactive Drugs 55:4, pages 402-410.
Read now
Read now
Miguel Ângelo Costa. (2023) A Dose of Creativity: An Integrative Review of the Effects of Serotonergic Psychedelics on Creativity. Journal of Psychoactive Drugs 55:3, pages 299-309.
Read now
Read now
Otto Simonsson & Simon B. Goldberg. (2023) Linkages between Psychedelics and Meditation in a Population-Based Sample in the United States. Journal of Psychoactive Drugs 55:1, pages 11-18.
Read now
Read now
Petter Grahl Johnstad. (2021) The Psychedelic Personality: Personality Structure and Associations in a Sample of Psychedelics Users. Journal of Psychoactive Drugs 53:2, pages 97-103.
Read now
Read now
Samuli Kangaslampi, Aino Hausen & Tarina Rauteenmaa. (2020) Mystical Experiences in Retrospective Reports of First Times Using a Psychedelic in Finland. Journal of Psychoactive Drugs 52:4, pages 309-318.
Read now
Read now
Peter S. Hendricks. (2018) Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy. International Review of Psychiatry 30:4, pages 331-342.
Read now
Read now
Articles from other publishers (86)
Bill Brennan & Alex Belser. 2024. EMBARK Psychedelic Therapy for Depression. EMBARK Psychedelic Therapy for Depression.
Paweł Orłowski, Justyna Hobot, Anastasia Ruban, Jan Szczypiński & Michał Bola. (2024) Naturalistic use of psychedelics does not modulate processing of self‐related stimuli (but it might modulate attentional mechanisms): An event‐related potentials study. Psychophysiology.
Crossref
Crossref
Daniel Villiger. (2024) Giving Consent to the Ineffable. Neuroethics 17:1.
Crossref
Crossref
D. Mulligan, A. K. O’Callaghan & A. Guerandel. (2023) “Don’t Look Up”: Eco-anxiety presenting in a Community Mental Health Service. Irish Journal of Psychological Medicine 41:1, pages 144-147.
Crossref
Crossref
Michael L. Lengieza. (2024) Eudaimonic self-expansion: The effects of eudaimonic reflections on nature connectedness. Journal of Environmental Psychology 94, pages 102231.
Crossref
Crossref
Tommaso Barba, Hannes Kettner, Caterina Radu, Joseph M. Peill, Leor Roseman, David J. Nutt, David Erritzoe, Robin Carhart-Harris & Bruna Giribaldi. (2024) Psychedelics and sexual functioning: a mixed-methods study. Scientific Reports 14:1.
Crossref
Crossref
Phil Wolfson & Gita Vaid. (2024) Ketamine-assisted psychotherapy, psychedelic methodologies, and the impregnable value of the subjective—a new and evolving approach. Frontiers in Psychiatry 15.
Crossref
Crossref
Simon GD Ruffell, Sam Gandy, WaiFung Tsang, Rono Lopez, Nathan O’Rourke, Arsalan Akhtar, Nige Netzband, Jack Hollingdale, Daniel Perkins & Jerome Sarris. (2024) Participation in an indigenous Amazonian-led ayahuasca retreat associated with increases in nature relatedness – a pilot study. Drug Science, Policy and Law 10.
Crossref
Crossref
Daniel Villiger & Manuel Trachsel. (2023) With great power comes great vulnerability: an ethical analysis of psychedelics’ therapeutic mechanisms proposed by the REBUS hypothesis. Journal of Medical Ethics 49:12, pages 826-832.
Crossref
Crossref
Alexander V. Lebedev, Kasim Acar, Otilia Horntvedt, Andrés E. Cabrera, Otto Simonsson, Walter Osika, Martin Ingvar & Predrag Petrovic. (2023) Alternative beliefs in psychedelic drug users. Scientific Reports 13:1.
Crossref
Crossref
Nuno Azevedo, Miguel Oliveira Da Silva & Luís Madeira. (2023) Ethics of Psychedelic Use in Psychiatry and Beyond—Drawing upon Legal, Social and Clinical Challenges. Philosophies 8:5, pages 76.
Crossref
Crossref
Patric Plesa & Rotem Petranker. (2023) Psychedelics and neonihilism: connectedness in a meaningless world. Frontiers in Psychology 14.
Crossref
Crossref
Amanda J. Wright & Joshua J. Jackson. (2022) Initiation of drug and alcohol use and personality development during adolescence. European Journal of Personality 37:4, pages 375-401.
Crossref
Crossref
Gina Ratkovic, Mike Sosteric & Tristan Sosteric. (2023) A case-study evaluation of the “Copenhagen Music Program” for psilocybin-assisted therapy. Frontiers in Psychology 14.
Crossref
Crossref
Caspar Montgomery & Inês Hipólito. (2023) Resurrecting Gaia: harnessing the Free Energy Principle to preserve life as we know it. Frontiers in Psychology 14.
Crossref
Crossref
Juuso Kähönen. (2023) Psychedelic unselfing: self-transcendence and change of values in psychedelic experiences. Frontiers in Psychology 14.
Crossref
Crossref
Nicolas Langlitz. (2023) The making of a mushroom people: Toward a moral anthropology of psychedelics beyond hype and anti‐hype. Anthropology Today 39:3, pages 10-12.
Crossref
Crossref
Katie NewtonSam G. Moreton. (2023) Self-Transcendent Positive Emotions as a Potential Mechanism Underpinning the Effects of Meaningful Psychedelic Experiences on Connectedness to Nature. Ecopsychology 15:2, pages 142-159.
Crossref
Crossref
Alexander Irvine, David Luke, Freya Harrild, Sam Gandy & Rosalind Watts. (2023) Transpersonal Ecodelia: Surveying Psychedelically Induced Biophilia. Psychoactives 2:2, pages 174-193.
Crossref
Crossref
Kadi Tulver, Karl Kristjan Kaup, Ruben Laukkonen & Jaan Aru. (2023) Restructuring insight: An integrative review of insight in problem-solving, meditation, psychotherapy, delusions and psychedelics. Consciousness and Cognition 110, pages 103494.
Crossref
Crossref
R.L. Carhart-Harris, S. Chandaria, D.E. Erritzoe, A. Gazzaley, M. Girn, H. Kettner, P.A.M. Mediano, D.J. Nutt, F.E. Rosas, L. Roseman, C. Timmermann, B. Weiss, R.J. Zeifman & K.J. Friston. (2023) Canalization and plasticity in psychopathology. Neuropharmacology 226, pages 109398.
Crossref
Crossref
Grant Jones, Joshua Lipson & Erica Wang. (2023) Examining associations between MDMA/ecstasy and classic psychedelic use and impairments in social functioning in a U.S. adult sample. Scientific Reports 13:1.
Crossref
Crossref
Nicolas Langlitz. (2023) What good are psychedelic humanities?. Frontiers in Psychology 14.
Crossref
Crossref
Benjamin A. Korman. (2023) Could classic psychedelics influence immigrants’ acculturation process? A narrative review contemplating how. Drug Science, Policy and Law 9.
Crossref
Crossref
Matthias Forstmann, Hannes S Kettner, Christina Sagioglou, Alexander Irvine, Sam Gandy, Robin L Carhart-Harris & David Luke. (2023) Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness. Journal of Psychopharmacology 37:1, pages 93-106.
Crossref
Crossref
Michael L. Lengieza, Rosemary Aviste & Janet K. Swim. 2023. Outdoor Environmental Education in the Contemporary World. Outdoor Environmental Education in the Contemporary World
49
81
.
Sabrina Correa da Costa & Mehmet Sofuoglu. 2023. Ethics and Clinical Neuroinnovation. Ethics and Clinical Neuroinnovation
153
171
.
Amy Isham, Patrick Elf & Tim Jackson. (2022) Self-transcendent experiences as promoters of ecological wellbeing? Exploration of the evidence and hypotheses to be tested. Frontiers in Psychology 13.
Crossref
Crossref
Ido Hartogsohn. (2022) Modalities of the psychedelic experience: Microclimates of set and setting in hallucinogen research and culture. Transcultural Psychiatry 59:5, pages 579-591.
Crossref
Crossref
Matthias Forstmann & Christina Sagioglou. (2022) New Insights Into the Clinical and Nonclinical Effects of Psychedelic Substances. European Psychologist 27:4, pages 291-301.
Crossref
Crossref
Sabrina Correa da Costa, Tyler Oesterle, Teresa A. Rummans, Elliot Richelson & Mark Gold. (2022) Psychedelic drugs for psychiatric disorders. Journal of the Neurological Sciences 440, pages 120332.
Crossref
Crossref
Victoria Amalie Nygart, Lis Marie Pommerencke, Eline Haijen, Hannes Kettner, Mendel Kaelen, Erik Lykke Mortensen, David John Nutt, Robin Lester Carhart-Harris & David Erritzoe. (2022) Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample. Journal of Psychopharmacology 36:8, pages 932-942.
Crossref
Crossref
Kelly Paterniti, Stephen Bright & Eyal Gringart. (2022) The Relationship Between Psychedelic Use, Mystical Experiences, and Pro-Environmental Behaviors. Journal of Humanistic Psychology, pages 002216782211110.
Crossref
Crossref
Maggie Kamila Kiraga, Kim P. C. Kuypers, Malin Vedoy Uthaug, Johannes G. Ramaekers & Natasha Leigh Mason. (2022) Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees. Frontiers in Psychiatry 13.
Crossref
Crossref
Elin Pöllänen, Walter Osika, Cecilia U. D. Stenfors & Otto Simonsson. (2022) Classic Psychedelics and Human–Animal Relations. International Journal of Environmental Research and Public Health 19:13, pages 8114.
Crossref
Crossref
Patric Plesa & Rotem Petranker. (2022) Manifest your desires: Psychedelics and the self-help industry. International Journal of Drug Policy 105, pages 103704.
Crossref
Crossref
Grant Jones, Joshua Lipson & Matthew K. Nock. (2022) Associations between classic psychedelics and nicotine dependence in a nationally representative sample. Scientific Reports 12:1.
Crossref
Crossref
Nicole Amada & Jacob Shane. (2022) Self-Actualization and the Integration of Psychedelic Experience: The Mediating Role of Perceived Benefits to Narrative Self-Functioning. Journal of Humanistic Psychology, pages 002216782210996.
Crossref
Crossref
H. T. McGovern, P. Leptourgos, B. T. Hutchinson & P. R. Corlett. (2022) Do psychedelics change beliefs?. Psychopharmacology 239:6, pages 1809-1821.
Crossref
Crossref
Joanna Kuc, Hannes Kettner, Fernando Rosas, David Erritzoe, Eline Haijen, Mendel Kaelen, David Nutt & Robin L. Carhart-Harris. (2021) Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey. Psychopharmacology 239:5, pages 1425-1440.
Crossref
Crossref
Grant Jones, Jocelyn A. Ricard, Joshua Lipson & Matthew K. Nock. (2022) Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample. Scientific Reports 12:1.
Crossref
Crossref
Charles L. Raison, Rakesh Jain, Andrew D. Penn, Steven P. Cole & Saundra Jain. (2022) Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States. Frontiers in Psychiatry 13.
Crossref
Crossref
Malin Vedøy Uthaug, Alan K Davis, Trevor Forrest Haas, Dawn Davis, Sean B Dolan, Rafael Lancelotta, Christopher Timmermann & Johannes G Ramaekers. (2021) The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects. Journal of Psychopharmacology 36:3, pages 309-320.
Crossref
Crossref
Grant M. Jones & Matthew K. Nock. (2022) Exploring protective associations between the use of classic psychedelics and cocaine use disorder: a population-based survey study. Scientific Reports 12:1.
Crossref
Crossref
Chris Letheby & Jaipreet Mattu. (2022) Philosophy and classic psychedelics: A review of some emerging themes. Journal of Psychedelic Studies 5:3, pages 166-175.
Crossref
Crossref
Mitch Earleywine, Fiona Low & Joseph De Leo. (2022) A Semantic Scale Network analysis of the revised Mystical Experiences Questionnaire: A call for collaboration. Journal of Psychedelic Studies 5:3, pages 156-165.
Crossref
Crossref
Christina Sagioglou & Matthias Forstmann. (2022) Psychedelic use predicts objective knowledge about climate change via increases in nature relatedness. Drug Science, Policy and Law 8, pages 205032452211298.
Crossref
Crossref
Grant M Jones & Matthew K Nock. (2022) Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes. Journal of Psychopharmacology 36:1, pages 57-65.
Crossref
Crossref
Grant M Jones & Matthew K Nock. (2022) Psilocybin use is associated with lowered odds of crime arrests in US adults: A replication and extension. Journal of Psychopharmacology 36:1, pages 66-73.
Crossref
Crossref
Kristof Janos Bodnar & Szabina Peter. 2022. Integrity of Scientific Research. Integrity of Scientific Research
227
234
.
Brian A. Pace & Neşe Devenot. (2021) Right-Wing Psychedelia: Case Studies in Cultural Plasticity and Political Pluripotency. Frontiers in Psychology 12.
Crossref
Crossref
Michael L. Lengieza & Janet K. Swim. (2021) The Paths to Connectedness: A Review of the Antecedents of Connectedness to Nature. Frontiers in Psychology 12.
Crossref
Crossref
Petter Grahl Johnstad. (2021) Day trip to hell: A mixed methods study of challenging psychedelic experiences. Journal of Psychedelic Studies 5:2, pages 114-127.
Crossref
Crossref
Maggie K. Kiraga, Natasha L. Mason, Malin V. Uthaug, Kim I.M. van Oorsouw, Stefan W. Toennes, Johannes G. Ramaekers & Kim P. C. Kuypers. (2021) Persisting Effects of Ayahuasca on Empathy, Creative Thinking, Decentering, Personality, and Well-Being. Frontiers in Pharmacology 12.
Crossref
Crossref
Nicolas Langlitz, Erika Dyck, Milan Scheidegger & Dimitris Repantis. (2021) Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics. Frontiers in Psychiatry 12.
Crossref
Crossref
Charlotte Martial, Géraldine Fontaine, Olivia Gosseries, Robin Carhart-Harris, Christopher Timmermann, Steven Laureys & Héléna Cassol. (2021) Losing the Self in Near-Death Experiences: The Experience of Ego-Dissolution. Brain Sciences 11:7, pages 929.
Crossref
Crossref
Sascha B. Thal, Stephen J. Bright, Jason M. Sharbanee, Tobias Wenge & Petra M. Skeffington. (2021) Current Perspective on the Therapeutic Preset for Substance-Assisted Psychotherapy. Frontiers in Psychology 12.
Crossref
Crossref
Harriet de Wit, Anya K. Bershad, William Hutchison & Michael Bremmer. (2021) Can MDMA Change Sociopolitical Values? Insights From a Research Participant. Biological Psychiatry 89:11, pages e61-e62.
Crossref
Crossref
Henry Lowe, Ngeh Toyang, Blair Steele, Henkel Valentine, Justin Grant, Amza Ali, Wilfred Ngwa & Lorenzo Gordon. (2021) The Therapeutic Potential of Psilocybin. Molecules 26:10, pages 2948.
Crossref
Crossref
Ari Brouwer & Robin Lester Carhart-Harris. (2020) Pivotal mental states. Journal of Psychopharmacology 35:4, pages 319-352.
Crossref
Crossref
H. Kettner, F. E. Rosas, C. Timmermann, L. Kärtner, R. L. Carhart-Harris & L. Roseman. (2021) Psychedelic Communitas: Intersubjective Experience During Psychedelic Group Sessions Predicts Enduring Changes in Psychological Wellbeing and Social Connectedness. Frontiers in Pharmacology 12.
Crossref
Crossref
Petter Grahl Johnstad. (2020) Who is the typical psychedelics user? Methodological challenges for research in psychedelics use and its consequences. Nordic Studies on Alcohol and Drugs 38:1, pages 35-49.
Crossref
Crossref
Elena Argento, Rielle Capler, Gerald Thomas, Philippe Lucas & Kenneth W. Tupper. 2021. Ayahuasca Healing and Science. Ayahuasca Healing and Science
171
188
.
Petter Grahl Johnstad. (2020) Cannabis as entheogen: survey and interview data on the spiritual use of cannabis. Journal of Cannabis Research 2:1.
Crossref
Crossref
Jamie E. Parnes, Shane D. Kentopp, Bradley T. Conner & Rachel A. Rebecca. (2020) Who takes the trip? Personality and hallucinogen use among college students and adolescents. Drug and Alcohol Dependence 217, pages 108263.
Crossref
Crossref
Colin G. DeYoung & Scott D. Blain. 2020. The Cambridge Handbook of Personality Psychology. The Cambridge Handbook of Personality Psychology
273
292
.
. 2020. The Cambridge Handbook of Personality Psychology. The Cambridge Handbook of Personality Psychology.
Adam Greif & Martin Šurkala. (2020) Compassionate use of psychedelics. Medicine, Health Care and Philosophy 23:3, pages 485-496.
Crossref
Crossref
Edward James, Thomas L Robertshaw, Mathew Hoskins & Ben Sessa. (2020) Psilocybin occasioned mystical‐type experiences. Human Psychopharmacology: Clinical and Experimental 35:5.
Crossref
Crossref
Sam Gandy, Matthias Forstmann, Robin Lester Carhart-Harris, Christopher Timmermann, David Luke & Rosalind Watts. (2020) The potential synergistic effects between psychedelic administration and nature contact for the improvement of mental health. Health Psychology Open 7:2, pages 205510292097812.
Crossref
Crossref
Max Wolff, Ricarda Evens, Lea J. Mertens, Michael Koslowski, Felix Betzler, Gerhard Gründer & Henrik Jungaberle. (2020) Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance. Frontiers in Psychiatry 11.
Crossref
Crossref
Sam G. Moreton, Luke Szalla, Rachel E. Menzies & Andrew F. Arena. (2019) Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics. Psychopharmacology 237:1, pages 21-32.
Crossref
Crossref
Sam Gandy. (2019) Psychedelics and potential benefits in “healthy normals”: A review of the literature. Journal of Psychedelic Studies 3:3, pages 280-287.
Crossref
Crossref
Hannes Kettner, Sam Gandy, Eline C. H. M. Haijen & Robin L. Carhart-Harris. (2019) From Egoism to Ecoism: Psychedelics Increase Nature Relatedness in a State-Mediated and Context-Dependent Manner. International Journal of Environmental Research and Public Health 16:24, pages 5147.
Crossref
Crossref
Christopher B. Germann. (2019) 5-Methoxy-N,N-dimethyltryptamine: An Ego-Dissolving Endogenous Neurochemical Catalyst of Creativity. Activitas Nervosa Superior 61:4, pages 170-216.
Crossref
Crossref
David Erritzoe, James Smith, Patrick M Fisher, Robin Carhart-Harris, Vibe G Frokjaer & Gitte M Knudsen. (2019) Recreational use of psychedelics is associated with elevated personality trait openness: Exploration of associations with brain serotonin markers. Journal of Psychopharmacology 33:9, pages 1068-1075.
Crossref
Crossref
Virginia Ballesteros. (2019) APPLIED MYSTICISM: A DRUG‐ENABLED VISIONARY EXPERIENCE AGAINST MORAL BLINDNESS. Zygon® 54:3, pages 731-755.
Crossref
Crossref
R. L. Carhart-Harris & K. J. Friston. (2019) REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics. Pharmacological Reviews 71:3, pages 316-344.
Crossref
Crossref
Edward James, Thomas L Robertshaw, Michael J Pascoe, Fiona M Chapman, Andrew D Westwell & Andrew P Smith. (2019) Using the pharmacy retail model to examine perceptions and biases of a UK population sample towards regulation of specific psychoactive drugs. Drug Science, Policy and Law 5, pages 205032451987612.
Crossref
Crossref
Orsolya Feher. (2018) Psychedelics and the media in the Visegrad countries. Journal of Psychedelic Studies 2:2, pages 78-88.
Crossref
Crossref
D. Erritzoe, L. Roseman, M. M. Nour, K. MacLean, M. Kaelen, D. J. Nutt & R. L. Carhart‐Harris. (2018) Effects of psilocybin therapy on personality structure. Acta Psychiatrica Scandinavica 138:5, pages 368-378.
Crossref
Crossref
Henrik Jungaberle, Sascha Thal, Andrea Zeuch, Ansgar Rougemont-Bücking, Maximilian von Heyden, Helena Aicher & Milan Scheidegger. (2018) Positive psychology in the investigation of psychedelics and entactogens: A critical review. Neuropharmacology 142, pages 179-199.
Crossref
Crossref
Christopher Timmermann, Leor Roseman, Luke Williams, David Erritzoe, Charlotte Martial, Héléna Cassol, Steven Laureys, David Nutt & Robin Carhart-Harris. (2018) DMT Models the Near-Death Experience. Frontiers in Psychology 9.
Crossref
Crossref
Taylor Lyons & Robin L Carhart-Harris. (2018) Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression. Journal of Psychopharmacology 32:7, pages 811-819.
Crossref
Crossref
R. L. Carhart-Harris, D. Erritzoe, E. Haijen, M. Kaelen & R. Watts. (2017) Psychedelics and connectedness. Psychopharmacology 235:2, pages 547-550.
Crossref
Crossref
Peter S Hendricks, Michael Scott Crawford, Karen L Cropsey, Heith Copes, N Wiles Sweat, Zach Walsh & Gregory Pavela. (2017) The relationships of classic psychedelic use with criminal behavior in the United States adult population. Journal of Psychopharmacology 32:1, pages 37-48.
Crossref
Crossref